FDA approves IND application for peanut allergy drug candidate 16-Sep-2021 By Jenni Spinner The US agency has given the go-ahead to Cour Pharmaceuticals to evaluate the safety and efficacy of CNP-201, a drug intended to treat peanut allergies.
Researchers call on manufacturers to provide excipient allergy info 18-Mar-2019 By Ben Hargreaves A study carried out by MIT researchers has found that 93% of medications contain excipients with the potential to cause an allergic reaction.
First generic EpiPen enters the market at half the cost 29-Nov-2018 By Maggie Lynch Teva’s EpiPen generic will reach market at a cost of $300 per pack, which matches the price of Mylan’s own generic version.
Fresenius recalls sodium chloride injection over possible allergic reaction 27-Nov-2018 By Maggie Lynch Fresenius Kabi voluntarily recalled 163 lots of sodium chloride injections, after the presence of latex was found within its packaging.